Nyloxin Chronic Pain Relief

Millions suffer from acute or chronic pain every year and the effects of pain exact a tremendous cost on our country in health care costs, rehabilitation and lost worker productivity, as well as the emotional and financial burden it places on patients and their families.

While acute pain is a normal sensation triggered in the nervous system to alert you to possible injury and the need to take care of yourself, chronic pain is different. chronic pain persists. Pain signals keep firing in the nervous system for weeks, months, even years.

Nyloxin provides all-natural anti-inflammatory analgesic pain relief that is non-toxic, non-narcotic, non-addictive, non-steroidal and contains no aspirin or acetaminophen. Safe to use without a prescription, it treats conditions that cause chronic pain.

The Chronic Pain Market

The global pain treatment market recorded sales of $22 Billion in 2010, rising at a compound annual growth rate of 8.9% since 2005. Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will decrease from $21.4 billion in 2012 to $18.3 billion in 2017, but will recover to $21.6 billion by 2022. The heterogeneity of pain necessitates a wide range of analgesics with different modes of action and delivery methods. As such, many different classes of drugs co-exist in the pain treatment market.

With over 100 Million Americans suffering from chronic pain, Nyloxin answers the call for a safe, effective, non-habit forming pain relief solution in a vast market place.